Volcano's Revolution rotational IVUS (intravascular ultrasound) cleared for sale in Japan:
This article was originally published in Clinica
Executive Summary
Following last month's Japanese approval for its s5i integrated IVUS (intravascular ultrasound) device (see Clinica No 1267, p 16), Volcano has received approval in the same country to market its Revolution 45 MHz rotational IVUS imaging catheter. The new approval covers use of the Revolution catheter - the highest frequency IVUS catheter available in Japan - on Volcano's IVG IVUS system. The Rancho Cordova, California firm has scheduled the Japanese launch of the catheter during the fourth quarter of this year. The Revolution catheter is already available in the US and Europe.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.